November 3, 2008
Despite all the pressures on pharma, and its increasingly competitive marketplace, the outlook for the industry continues to be positive.
 |
November 3, 2008
Typically, companies have outsourced back-office operations or routine activities. Now they should be thinking about partnering to obtain strategic capabilities.
|
November 3, 2008
Most of the innovative products are now coming from hundreds of emerging companies worldwide. The objective is no longer solely to identify the right asset, but to get access and secure it through more and more complex deals and value-sharing partnerships
|
November 3, 2008
By:Marylyn Donahue
Is a phoenix beginning to rise from this year's layoffs, expiring patents, and regulatory setbacks? Ask the consultants...
|
November 3, 2008
The theme for the pharmaceutical and biotech industries in 2009 is change.
|
November 3, 2008
"Specialized consultants will have the opportunity to work on a larger volume of strategic and operationally focused projects. Clients will increasingly focus on receiving value for their money"
|
November 3, 2008
Comm op can offer valuable strengths for difficult times - analytic, systematic, managerial, and strategic - and provide an untapped resource for senior management.
|
November 3, 2008
Evidence-based consultants can, for example, access data rapidly, analyze it, and extract critical strategic and market insights - while traditional players are still turning to others for data and, often, insights.
|
November 3, 2008
"Increased outsourcing will yield lower costs, but also will increase the potential for risk (less control of suppliers, materials, and raining), as well as less flexibility when it comes to responding to business changes"
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
